Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
Boston Scientific develops medical devices and technologies used by healthcare professionals to treat patients across a range of conditions. The page (hosted on the axonics.com domain) presents the company as a medical device manufacturer focused on patient care.
3 investors
Bain Capital Life Sciences is an investment firm that backs pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies worldwide. It pursues opportunities across the value chain—including inflection capital, growth capital, fallen angels, and private equity collaborations—to advance treatments for patients with unmet medical needs.
3 investors
Bairitone develops a wearable patch-based system that maps airway vibrations to detect sleep apnea obstruction causes without MRI, X-ray, or ultrasound. The platform provides dynamic airway mapping and precision therapy guidance for sleep health providers and patients.
3 investors
Basking Biosciences develops therapeutics for thrombosis, vascular biology, and ischemic disease. The company focuses on stroke and cardiovascular applications.
3 investors
Baymatob develops Oli, an AI-guided maternal and fetal monitoring platform, including Oli PPH, a device aimed at reducing postpartum hemorrhage, a leading cause of preventable maternal death. The company serves the women's health and maternal healthcare market and has received FDA Breakthrough Device Designation.
3 investors
BeSound provides radiation-free breast ultrasound imaging with AI-powered detection, aimed at women — particularly those with dense breast tissue — who may be underserved by mammography. It operates a physical clinic in Los Angeles and a planned mobile unit, offering 20-minute scans with results in 24-48 hours.
3 investors
Bexorg is a biotech platform for CNS drug discovery built on a whole-brain perfusion model that allows manipulation and recording of cellular activity in intact human brains. The company serves pharmaceutical researchers developing treatments for brain diseases.
3 investors
Beyond Barriers Therapeutics develops BBT-101, an intranasal therapy for mild and moderate concussions intended for rapid deployment at the point of injury. The company focuses on providing the first FDA-approved frontline treatment for brain injuries across military, athletic, and civilian populations.
3 investors
Biofidelity develops genomic biomarker testing technologies—its Aspyre and Enspyre products—for cancer detection, treatment selection, and minimal residual disease monitoring. The company serves oncology providers and patients with precision genomic diagnostics across the cancer patient journey.
3 investors
Biogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
3 investors
Bioliberty develops the Lifehub Clinic system, combining soft robotic wearables, gamified therapy, and AI insights to help clinicians deliver physical and occupational therapy to patients recovering from mobility issues such as stroke. The system is built for inpatient and outpatient care settings, supporting patient movement and strength training.
3 investors
Biomeme develops a mobile molecular testing platform that brings laboratory-grade PCR diagnostics to the point of need, serving clinical partners and organizations that need real-time detection of biological threats and diseases. The company operates a vertically integrated facility spanning biology, engineering, software, and manufacturing.
3 investors
BioOra develops and manufactures CAR-T cell therapies from New Zealand, targeting patients with cancer who currently lack access to these treatments in their local regions. The company aims to improve treatment access, reduce delays, and enable scalable delivery of advanced cell therapies across underserved regions globally.
3 investors
Aika is an operating system that uses AI and automation to orchestrate clinical trial development end-to-end, helping organizations accelerate protocol creation, prevent amendments, and interpret complex datasets across all stages of trial development.
3 investors
Biorez develops the BioBrace, a bioinductive implant combining Type I collagen with PLLA microfilaments to reinforce and support soft tissue and tendon healing, including rotator cuff and foot & ankle repairs. The implant is used in open and arthroscopic surgical procedures for soft tissue augmentation.
3 investors
Biosapien develops treatments for cancer that are delivered locally to shrink tumors, relieve symptoms, and reduce the need for surgeries.
3 investors
BioT provides cloud infrastructure for medical device companies to connect devices, manage clinical data, and deliver connected care, with built-in security and regulatory compliance (FDA, HIPAA, GDPR, MDR). Its no-code/low-code platform lets device makers add cloud services, build custom modules, and integrate with EHRs, CRMs, and third-party systems.
3 investors
Bioventus develops orthobiologics and pain treatment products for orthopedic care, offering therapies such as the StimRouter neurostimulation device for chronic peripheral nerve pain. Its portfolio serves patients, physicians, and payers in the medical device and healing space.
3 investors
Blackrock Neurotech develops a neurotechnology platform, including brain-computer interface systems, aimed at improving patient lives and treating neurological conditions. It builds implantable neural interface technology for medical and research applications.
3 investors
Genetix Biotherapeutics (formerly bluebird bio) develops gene therapies for patients with rare genetic diseases including sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy. The therapies use modified blood stem cells to restore function of affected genes and offer potential cures rather than symptom management.
3 investors
Boston Heart Diagnostics provides cardiovascular diagnostic testing and lifestyle management programs, serving healthcare providers and their patients. Its approach combines diagnostic services with care management to support heart health.
3 investors
The company develops non-cathartic virtual colonoscopy technology to enable early detection of colorectal cancer, which ranks first in cancer incidence and second in cancer mortality in Japan. The solution aims to overcome patient resistance to traditional colonoscopy screening by offering a high-accuracy examination without laxative preparation.
3 investors
Boundless Bio develops precision oncology medicines targeting ecDNA-amplified cancers, specifically creating a new category of ecDNA-directed therapies for patients with oncogenic alterations.
3 investors
BrainKey develops artificial intelligence and medical imaging analysis tools for neuroimaging data interpretation. The company serves physicians and patients by making brain anatomy measurable, visible, and more interpretable through advanced analytical software.
3 investors